Springfield, part of Ramsay Health Care UK, is delighted to announce that men suffering from a benign enlarged prostate (Benign Prostatic Hyperplasia) will be able to receive robotic Aquablation therapy at the hospital.
It is estimated that 3 million men in the UK have lower urinary tract symptoms associated with Benign Prostatic Hyperplasia (BPH) and around 35,000 men in the UK will require surgical intervention for this condition. Historically, the procedures available for the treatment of this condition, whilst providing effective symptom relief, may have recognised complications such as incontinence, erectile or ejaculatory dysfunction.
Aquablation therapy is an advanced, minimally invasive treatment for BPH (Benign Prostatic Hyperplasia) that uses imaging, robotics, and a heat-free waterjet to provide long-lasting relief with low rates of complications. Clinical studies have shown that Aquablation Therapy offers significant symptom relief and low complication rates, regardless of prostate size or shape.
Nick Jackson, Hospital Director at Springfield Hospital commented:“We are proud and delighted to be able to offer this new minimally invasive robotic surgery to our patients. At Springfield, we put our patients' needs at the heart of everything we do. With state-of-the-art technology and a focus on delivering high quality care, we ensure patients receive the treatment they need and support beyond after their surgery or treatment. Supporting our local community for their healthcare requirements is of absolute importance to us, as recognised in our company ethos of ‘People caring for People’.”
For more information about Aquablation or to schedule a consultation, please visit the Springfield Hospital website or contact our patient services team.